MicroVention is a rapidly growing medical device company that has pioneered the development of catheter-based, minimally invasive, neuroendovascular technologies that provide therapeutic advantages for neurovascular disorders. Since the launch of their First Generation HydroCoil™ embolic system in 2003, MicroVention has expanded its portfolio to every corner of the neuroendovascular industry—now producing Best-in-Class Embolic Coils, Intrasaccular Devices, Coil-Assist Stents, and Flow Diverters. With the celebration of their 3rd FDA Premarket Approval (PMA) in an 18-month timeframe, MicroVention now holds more PMA’s than any other company in their industry as of January 2020. Headquartered in the sunny Southern California city of Aliso Viejo, California, MicroVention is a short distance from beaches, mountains, and hiking trails. Associates enjoy a positive work-life balance with perks like an on-site fitness center, continuing education programs, community service opportunities, talent development, and much more. Our company is filled with incredible team players that collaborate, are innovative, and are motivated daily to develop the best-in-class neuroendovascular devices. In 2022, MicroVention was certified in the U.S. and in Costa Rica as a Great Place to Work by Great Places to Work; the global authority on workplace culture. Our incredible Associates are the ones that make this A great Place to work! MicroVention is committed to developing and manufacturing the highest quality products for customers and patients while maintaining a strong Clinical Research and R&D focus to respond quickly to customer needs and advance therapeutic modalities. MicroVention is dedicated to the development and commercialization of innovative endovascular technologies that provide a meaningful improvement in patient lives. Innovation Starts With You! See more at http://www.microvention.com
Lien externe pour MicroVention-Terumo
MicroVention-Terumo a republié ceci
MicroVention-Terumo has announced the recent publication in #jnis of one-year results from CLEVER—a study that sought to provide a clinical evaluation with the Woven EndoBridge (WEB) 17 device in treating ruptured and unruptured #aneurysms. #snis2024 Society of NeuroInterventional Surgery Laurent SPELLE Adam Arthur Carsten Schroeder
MicroVention-Terumo a republié ceci
That’s a wrap, #SNIS2024! Thank you to the physicians, fellows, program partners, and MicroVention Associates who made our week in Colorado Springs as successful as it was fun. See you next year in Nashville, Tennessee for SNIS 2025! #teamwork #neurointervention #microvention
MicroVention-Terumo a republié ceci
Dr. Stavropoula Tjoumakaris, Chair of SNIS 21st Annual Meeting, shared why diversity drives leadership. "First off, we are now multidisciplinary with neurology, radiology, and neurosurgery backgrounds. It’s important that the composition of our members be diverse in terms of gender, race, and underrepresented groups,” said Dr. Tjoumakaris, Professor of Neurosurgery and Radiology at Thomas Jefferson University Hospital. “We have remarkable women leaders advancing diversity in our field.” Join MicroVention at #SNIS2024 Drinks & Discussion hosted by the Women in Neurointervention Committee today from 5:30-7:30 pm in Broadmoor Hall B. #womeninneuro #neurovascular Stavropoula Tjoumakaris MD, MBA, FAANS, FACS, FAHA Society of NeuroInterventional Surgery
MicroVention-Terumo a republié ceci
We brought home the SNIS Foundation 5K Fun Run trophy this morning. Congratulations to our very own Alexandra Rose Pink-Fahrion, MicroVention Associate Product Manager, for winning first place. Thank you SNIS for making wellness a priority at #SNIS2024. We’re proud to have Run for Research! #wellness #neurointervention #microvention Society of NeuroInterventional Surgery
MicroVention announces the recently published results of the CLinical EValuation of WEB 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms at #SNIS2024. Visit Booth #521 to celebrate the Five-Year Anniversary of WEB Aneurysm Embolization System with more than 10,000 Units Sold in the United States. Press release: https://lnkd.in/gaUdKFCy #WEBdevice #OneandDone #microvention #neurovascular
MicroVention-Terumo a republié ceci
We had the privilege of gathering with customers during today's Meet & Greet with Bill Phillips, our newly appointed Chief Commercial Officer at MicroVention-Terumo. Thank you to everyone who joined us to discuss how we can further our partnership in delivering neurovascular solutions to patients worldwide. #SNIS2024 #neurointervention #microvention William Phillips Kristin Leary
MicroVention-Terumo a republié ceci
#SNIS2024 is here. MicroVention has an exciting program planned this week with opportunities to engage with physicians and MicroVention leadership, hear clinical case presentations, and receive hands-on experience with our innovative solutions. Plus, we're sponsoring a Fellows Course on Thursday at 5:30 pm in Bartolin 211. Visit us in Booth #521 to say hello and learn more! #neurointervention #microvention
MicroVention-Terumo a republié ceci
"At MicroVention, SNIS is a highlight of our year, a key event in the neurovascular community. Our customers can count on us for ongoing product innovation and compelling clinical data that demonstrate how our solutions benefit patients globally," says Carsten Schroeder, President & CEO of MicroVention. We look forward to meeting you in Booth #521 at #SNIS2024 Colorado Springs! #neurointervention #microvention
A day filled with laughter, learning, and family fun! Our Costa Rica office held an Employee Family Day and it was a fantastic success! Our Associates brought their loved ones for a memorable day of games, and activities including a facilities tour and a hands-on experience with our innovative products. Thank you to everyone who joined us and made this event so special. Here’s to celebrating the wonderful people who make our company a great place to work! #EmployeeFamilyDay #LifeatMicroVention